Postpartum substance use disorder requires individualized medical and psychiatric care. Medication for opioid use disorder, breastfeeding decisions, postpartum depression, overdose risk, and infant safety should be managed with qualified obstetric, addiction, pediatric, and mental health professionals as appropriate.
THE POSTPARTUM PERIOD CAN BE A HIGH-RISK TRANSITION
Postpartum substance use disorder care must account for a major physical, hormonal, emotional, and practical transition at the same time recovery may already be fragile. Sleep deprivation, pain, isolation, stigma, relationship stress, infant care, and changes in medical follow-up can all affect risk.
ACOG recommends that postpartum care include assessment of mood, chronic conditions, sleep, infant care, and substance use. SAMHSA has also emphasized continuity of perinatal substance use treatment, especially for opioid use disorder, because the months after delivery can be a period of increased recurrence and overdose vulnerability.
DO NOT INTERRUPT EFFECTIVE OPIOID USE DISORDER TREATMENT WITHOUT A PLAN
For people receiving methadone or buprenorphine, postpartum care generally emphasizes continuity rather than abrupt discontinuation. ACOG and other clinical guidance warn that the postpartum period is a vulnerable time and that medication changes should be based on symptoms and clinical assessment.
Recent research continues to support the importance of medication continuity. A 2026 cohort study found that longer duration of medication for opioid use disorder during pregnancy and early postpartum was associated with lower risk of overdose or death during the first postpartum year.
MENTAL HEALTH SCREENING IS ESSENTIAL
Depression, anxiety, trauma symptoms, intrusive thoughts, and severe sleep disruption can overlap with substance use and relapse risk after delivery. Postpartum depression or anxiety should not be dismissed as ordinary stress, and substance use should not be treated without considering mental health.
Any suicidal thinking, psychosis, mania, severe confusion, or thoughts of harming the infant require urgent professional evaluation. Perinatal mental health and addiction care should be coordinated rather than handled in separate silos.
INFANT CARE CHANGES TREATMENT PLANNING
Treatment decisions may affect breastfeeding, sleep arrangements, transportation, childcare, custody concerns, and the ability to attend appointments. Programs should ask what support the parent has at home and what practical barriers could interrupt treatment.
For some parents, residential care may be appropriate; for others, outpatient or integrated perinatal programs may better fit infant-care needs. The right level of care should be based on clinical severity, safety, environment, and available support.
OVERDOSE PREVENTION REMAINS IMPORTANT AFTER DELIVERY
Tolerance can change during periods of reduced opioid use, and relapse after a period of abstinence can carry overdose risk. Postpartum treatment planning should include overdose education and naloxone access when opioids are involved, along with attention to sedating combinations such as opioids with benzodiazepines or alcohol.
Recurrence of use should trigger rapid re-engagement with care, not shame or abandonment. The goal is to keep the parent connected to treatment through a period when medical and family demands are unusually high.
RECOVERY SUPPORT MUST FIT REAL LIFE
Continuity after discharge may require coordinated obstetric care, primary care, addiction treatment, mental health services, peer support, pediatric appointments, transportation, and childcare. A plan that looks good on paper but cannot be followed with a newborn is not a practical plan.
Family support can help when it respects the parent’s treatment, privacy, and autonomy. Recovery is strengthened when the parent is treated as a whole person rather than only as a patient or only as a caregiver.
FREQUENTLY ASKED QUESTIONS
Is relapse risk higher after delivery?
The postpartum period can be a time of increased vulnerability, particularly for opioid use disorder, making continuity of treatment and overdose prevention especially important.
Should methadone or buprenorphine be stopped after pregnancy?
Not routinely. Medication decisions should be individualized, and abrupt discontinuation can increase risk. Continue treatment unless qualified clinicians recommend a carefully planned change.
Can postpartum depression and substance use happen together?
Yes. Mood and anxiety disorders can co-occur with substance use and should be assessed together.
Can residential treatment work for a postpartum parent?
Sometimes, but program fit depends on medical needs, psychiatric risk, infant-care arrangements, breastfeeding considerations, childcare, family support, and the appropriate level of care.
Recommended Reading
- Women’s Rehab in Mexico: https://oceanica-usa.com/womens-rehab-in-mexico-gender-responsive-care/
- Postpartum Depression Treatment: https://oceanica-usa.com/postpartum-depression-treatment-when-its-more-than-baby-blues/
- Family Support for Addiction: https://oceanica-usa.com/family-support-for-addiction-how-loved-ones-heal-too/
- Services and Programs at Oceánica
EXTERNAL REFERENCE LINKS
- ACOG – Optimizing Postpartum Care
- SAMHSA – Healthy Starts: Postpartum OUD Care Transitions
- ACOG – Opioid Use and Opioid Use Disorder in Pregnancy
- Oceánica Conecta
Oceánica is a CARF-accredited residential treatment center in Mazatlán, Mexico. Treatment recommendations and program fit are assessed individually. This article is informational and not medical advice. Call (213) 527-3377 or visit oceanica-usa.com.





